TI
EBS icon

Trexquant Investment’s Emergent Biosolutions EBS Stock Holding History

Trexquant Investment’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.35M Buy
524,233
+222,544
+74% +$2.3M 0.03% 702
2025
Q4 		$3.73M Sell
301,689
-224,599
-43% -$2.41M 0.03% 728
2025
Q3 		$4.64M Sell
526,288
-25,142
-5% -$196K 0.05% 578
2025
Q2 		$3.52M Buy
551,430
+101,809
+23% +$583K 0.04% 664
2025
Q1 		$2.19M Sell
449,621
-251,896
-36% -$2.09M 0.03% 838
2024
Q4 		$6.71M Buy
701,517
+261,099
+59% +$2.4M 0.08% 406
2024
Q3 		$3.68M Buy
+440,418
New +$4M 0.05% 594
2023
Q2 		– Sell
-62,698
Closed -$650K – 1522
2023
Q1 		$650K Buy
+62,698
New +$758K 0.02% 890
2022
Q4 		– Sell
-30,089
Closed -$632K – 1449
2022
Q3 		$632K Buy
30,089
+14,412
+92% +$401K 0.02% 713
2022
Q2 		$487K Sell
15,677
-32,159
-67% -$1.1M 0.02% 837
2022
Q1 		$1.96M Buy
+47,836
New +$2.11M 0.09% 266
2021
Q4 		– Sell
-14,000
Closed -$701K – 1377
2021
Q3 		$701K Buy
+14,000
New +$848K 0.06% 413
2021
Q2 		– Sell
-3,942
Closed -$366K – 1183
2021
Q1 		$366K Buy
+3,942
New +$404K 0.03% 655
2020
Q4 		– Sell
-17,221
Closed -$1.78M – 1124
2020
Q3 		$1.78M Buy
+17,221
New +$1.86M 0.11% 248
2020
Q2 		– Sell
-8,861
Closed -$513K – 1216
2020
Q1 		$513K Buy
+8,861
New +$511K 0.04% 648
2018
Q1 		– Sell
-10,635
Closed -$494K – 1144
2017
Q4 		$494K Buy
+10,635
New +$448K 0.05% 516
2017
Q1 		– Sell
-6,111
Closed -$201K – 1135
2016
Q4 		$201K Buy
+6,111
New +$183K 0.03% 820
2016
Q2 		– Sell
-10,900
Closed -$396K – 925
2016
Q1 		$396K Buy
+10,900
New +$385K 0.05% 648
2015
Q3 		– Sell
-8,600
Closed -$283K – 1084
2015
Q2 		$283K Sell
8,600
-23,600
-73% -$732K 0.03% 831
2015
Q1 		$926K Buy
+32,200
New +$924K 0.09% 406

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Trexquant Investment's EBS Position: Q1 2026 in Review

Trexquant Investment increased its Emergent Biosolutions (EBS) stake by 74% in Q1 2026, buying an estimated $2.3M and bringing the position to 524,233 shares worth $4.35M. The position accounts for 0.03% of the portfolio, ranked #702.

Trexquant Investment first reported a position in EBS in Q1 2015 and has held it in 20 quarters since. The position peaked at $6.71M in Q4 2024. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Trexquant Investment held 524,233 shares of Emergent Biosolutions worth $4.35M as of Q1 2026.
  • Trexquant Investment bought 222,544 Emergent Biosolutions shares in Q1 2026, an estimated $2.3M.
  • Emergent Biosolutions made up 0.03% of Trexquant Investment's portfolio in Q1 2026, its #702 holding.
  • Trexquant Investment first reported a position in Emergent Biosolutions in Q1 2015 and has held it in 20 quarters since.
  • Trexquant Investment's Emergent Biosolutions position peaked at $6.71M in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.